Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Carcinoma Endometrioid

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Carcinoma Endometrioid:

Pubmed Logo
Ovarian cancer update: lessons from morphology, molecules, and mice.
Ovarian carcinomas are a heterogeneous group of neoplasms. Pathologists...
18th November, 2009
Department of Pathology, University of Michigan Health System, Ann Arbor, Arch Pathol Lab Med. 2009 Nov;133(11):1775-81.
[Expression of microRNAs in endometrioid adenocarcinoma]
OBJECTIVE: To analyze miRNA expression profile of endometrioid...
18th November, 2009
Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Zhonghua Yi Xue Za Zhi. 2009 May 19;89(19):1365-7.
Endometrioid adenocarcinoma arising from endometriosis of the uterine cervix: a case report.
Endometrioid adenocarcinoma arising from endometriosis of the uterine...
7th November, 2009
Department of Obstetrics and Gynecology, Gangneung Asan Hospital, J Korean Med Sci. 2009 Aug;24(4):767-71. Epub 2009 Jul 30.
DOI Direct Link
[MR Imaging of primary ovarian tumors with pathologic correlation]
Ovarian tumors are classified based on the cell of origin into epithelial...
29th October, 2009
Service d'Imagerie medicale, Hopital Lapeyronie, 371, avenue du Doyen J Radiol. 2009 Jul-Aug;90(7-8 Pt 1):787-802.
DOI Direct Link
Laparoscopic systemic retroperitoneal lymphadenectomy for women with low-risk early endometrial cancer.
INTRODUCTION: There is no consensus on the extent of lymphadenectomy and...
17th October, 2009
Department of Obstetrics and Gynecology, Kangbuk Samsung Hospital, Ann Acad Med Singapore. 2009 Jul;38(7):581-6.

View more research publications.

Press Releases About Carcinoma Endometrioid:

BioPortfolio Logo
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting 17th November, 2009 Oncolytics Biotech Inc.
CALGARY, Nov. 17 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced updated results from a Phase I/II U.K.
Oncolytics Biotech(R) Inc. Collaborators to Present Updated Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting 16th November, 2009 Oncolytics Biotech Inc.
CALGARY, Nov. 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced that a poster presentation covering updated
Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting 29th October, 2009 Onyx Pharmaceuticals, Inc.
-- Late Breaker #9 First-in-men Demonstration of Sorafenib Plus TACE for the Treatment of Advanced Hepatocellular Carcinoma (SOCRATES trial) -- Dr. Andreas Erhardt, Klinik fur
Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma 19th October, 2009 Jennerex, Inc.
SAN FRANCISCO, Oct. 19 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted
AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on Perifosine (KRX-0401) for the Treatment of Advanced Metastatic Renal Cell Carcinoma at 8th International Kidney Cancer Symposium in Chicago 29th September, 2009 AETERNA ZENTARIS INC.
Perifosine Continues to Demonstrate Impressive Efficacy, Safety and Tolerability in Metastatic Renal Cell Carcinoma Patients who Progressed after Failing Treatment with both a VEGF

BioNews Results for Carcinoma Endometrioid:

RSS Logo
BioPortfolio Logo
Low membranous expression of beta-catenin and high mitotic count predict poor prognosis in endometrioid carcin
Nature:  Oct 27 2009 5:55PM Matching: carcinoma endometrioid

Carcinoma Endometrioid Patents:

USPTO Logo
US Patent No.Title
7452551 Targeted compositions for diagnostic and therapeutic use
6642013 Extracellular serine protease
6602674 Uses of antileukoprotease in carcinoma
6548047 Thermal preactivation of gaseous precursor filled compositions
6521211 Methods of imaging and treatment with targeted compositions

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Carcinoma Endometrioid scientists - we have details of around 116 individuals working on Carcinoma Endometrioid .


This page has been viewed 325 times
Recent Search Terms used to find this page: endometriod carcinoma | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Carcinoma Endometrioid across BioPortfolio, or for Carcinoma Endometrioid Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.